James Lindsay

Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma

E. Cerami, D. D. Del Valle, S. Kim-Schulze, 2024, Cancer research communications.

Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy.

S. Harmon, B. Turkbey, H. Maecker, 2023, Cancer cell.